| Peer-Reviewed

The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer

Received: 22 November 2021     Accepted: 8 December 2021     Published: 24 December 2021
Views:       Downloads:
Abstract

Background: Colorectal cancer has high incidence and mortal rate in China. Chronic inflammatory intestine diseases are ascribed to precancerous lesion of colorectal cancer because of its close relationship with each other. TCM therapy has good effect in the prevention and treatment of inflammatory bowel diseases related colorectal cancer. Objective: To explore the preventive and therapeutic effects of Coptis chinensis and traditional Chinese medicine compound containing Coptis chinensis on inflammatory bowel disease and colorectal cancer. Methods: This paper reviews the sections in classical TCM books and recent report of clinical and experimental research on the formulars composed of Coptidis Rhizoma and the single drug in treating ulcerative colitis, intestinal polyps and colorectal cancer. By analyzing the data reported in the original literature, The mostly applied herbal formulas in the clinic including Gegen Qinlian Decoction, Dark Plum Pill and Banxia Xiexin Decoction were studied in detail. Results: Coptidis Rhizoma has the function of clearing away heat and drying dampness, purging fire and detoxification, benefiting intestine and stopping diarrhea. Several formulas composed of Coptidis Rhizoma are applied to treat inflammatory bowel diseases and colorectal cancer. Conclusion: Coptidis Rhizoma and its composition has the function of inhibiting intestinal inflammation, regulating intestinal flora, protecting intestinal barrier, and etc.

Published in International Journal of Chinese Medicine (Volume 5, Issue 4)
DOI 10.11648/j.ijcm.20210504.11
Page(s) 53-56
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Coptidis Rhizoma, Inflammatory Bowel Diseases, Colorectal Cancer, Clinical Study, Experimental Research

References
[1] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin. 2016, 66 (2): 115-132.
[2] Nitin Singh, Deepak Baby, Jagadish Prasad Rajguru et al. Inflammation and Cancer. Ann Afr Med, Jul-Sep 2019; 18 (3): 121-126.
[3] Connie I Diakos, Kellie A Charles, Donald C McMillan, et al. Cancer-related infl ammation and treatment eff ectiveness. Lancet Oncol, 2014 Oct; 15 (11): e493-503.
[4] Jennifer J Liang, Ian Bissett, Matthew Kalady, et al. Importance of serrated polyps in colorectal carcinogenesis. ANZ J Surg, 2013 May; 83 (5): 325-30.
[5] XU Chao, ZHOU Qing. Discussion on the focus of Traditional Chinese Medicine Intervention based on the Transformation of Early Intestinal Inflammation into Cancer. World Chinese Medicine, 2020, Sept; 15 (18): 2819-2822.
[6] WANG Junyi, CHENG Haibo, ZHOU Zhongying. Discussion on Colorectal Precancerous Lesions Based on the Traditional Chinese Medicine Theory. Journal of Traditional Chinese Medicine, 2018, Dec; 59 (21): 1819-1823.
[7] GUO Renqing. National TCM Master ZHOU Zhongying's Prescriptive Principle on Colorectal Cancer: Data Mining Approach. Journal of Liao Ning University of TCM, 2019, Apr; 21 (04): 142-145.
[8] CHEN Lihong, TANG Yvping, WANG Qiang. Advances in studies on Gegen Qinlian Decoction. CHINESE TRADITIONAL AND HERBAL DRUGS. 2010, June; 41 (4): Att. 10-12.
[9] XIN Fubing. 47 patients of UC treated by Dark Plum Pill. MODERN TRADITIONAL CHINESE MEDICINE. 2011, June; 31 (02): 20-21.
[10] LI Kai. The Clinical and Basic Research of Pungent Dispersion Bitter Purgation Method and Banxia Xiexin Decoction on the Treatment of Colon Cancer. China Academy of Chinese Medical Science. 2015.
[11] YV Tao. The Experience of Treating Ulcerative Colitis with GGQL. MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE. 2008, May; 17 (5): 763.
[12] CHEN Na, CHEN Dong, ZHANG Lei. Treating Colonic Polyp with TCM. Hebei Journal of Traditional Chinese Medicine. 2014, 36 (06): 837-838.
[13] WANG Bujiang, LIO Yvan. The Effect of GGQL on the pathological injury, inflammatory reaction and Intestinal Microecology of colonic cancer mice. Modern Practical Medicine. 2020, Dec; 32 (10): 1185-1188.
[14] LI Yi, GUO Lihua. LI Siwen treat diarrhea of postoperative colorectal cancer patients with GGQL. CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE. 2010, Aug; 17 (6): 85-86.
[15] GAO Dong, SHAO Xi-feng. Efficacy of Puerariae and Scutellariae and Coptidis Decoction in Treatment of Patients with Ulcerative Colitis and Its Effects on Inflammatory Reaction and Immune Function. Medical & Pharmaceutical Journal of Chinese People's Liberation Army. 2018, Nov; 30 (10): 89-92.
[16] ZHENG Caihua, CHANG Yvjvan, ZHANG Na, et al. Professor GUO Guangye’s Experience in Treatment of Patients with Ulcerative Colitis with modified Dark Plum Pill. Journal of Hebei Traditional Chinese Medicine and Pharmacology. 2018, Sep; 33 (4): 58-61.
[17] Zhang Lingyun. Observation of The Clinical Therapeutic Effect onPreventing Colonic Adenoma Postoperative patients’ Recurrence and Canceration Applying Modified "WuMeiWan". Nanjing University of Chinese Medicine. 2017.
[18] WANG Sai, XU Xin, ZHANG Mengzhe, et al. Professor JIANG Shiqing’s Experience of treating colorectal cancer on the base of syndrome differentiation of JVE YIN Channel. ACTA CHINESE MEDICINE. 2016, April; 31 (4): 467-469.
[19] HU Chuanwen, JIANG Hongjuan, ZHENG Xiaochun, et al. Effect of Banxia Xiexin Tang Combined with Retention Enema on Ulcerative Colitis at Remission Stage and on Levels of Intestinal Bacteria. JOURNAL OF NEW CHINESE MEDICINE. 2020, Feb; 52 (03): 10-12.
[20] LI Jicong. The Experience of Treating Discomfort of Patients of Polyp of Peptic Tract after operation with BXXX. Yiyao Qianyan. 2018, Sep; 8 (22): 326-327.
[21] WANG Xiaoyan. Professor Baojin Hua's Experience in Treatment Colon Carcinoma with Banxia Xiexin Decoction. China Journal of Chinese Medicine. 2019, July; 34 (06): 1201-1204.
[22] Kamath S, Skeels M, Pai A. Significant differences in alkaloid content of Coptis chinensis (Huanglian), from its related American species. Chin Med, 2009, Aug; 4 (1): 17-20.
[23] Thao Quyen Cao, Quynh-Mai Thi Ngo, Su Hui Seong. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis. Bioorg Chem, 2018 Apr; 77: 625-632.
[24] Hui Teng, Yong Hee Cho. Optimization of ultrasonic-assisted extraction of bioactive alkaloid compounds from rhizoma coptidis (Coptis chinensis Franch.) using response surface methodology. Food Chem, 2014 Jan 1; 142: 299-305.
[25] Fan G, Tao L H, Yue Q H, et al. Metabolic discrimination of Rhizoma Coptidis from different species using 1H NMR spectroscopy and principal component analysis [J]. Planta Med, 2012, April; 78 (6): 641-648.
[26] Ning Li, Lili Gu, Linlin Qu. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells. Eur J Pharm Sci, 2010 Apr 16; 40 (1): 1-8.
[27] Shao-Jung Wu, Trong-Ming Don, Cheng-Wei Lin. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier. Mar Drugs, 2014 Nov 24; 12 (11): 5677-97.
[28] Rodrigo Alzamora, Fiona O'Mahony, Wing-Hung Ko. Berberine Reduces cAMP-Induced Chloride Secretion in T84 Human Colonic Carcinoma Cells through Inhibition of Basolateral KCNQ1 Channels. Front Physiol, 2011 Jun 30; 2: 33.
[29] Jiang G, Li L, Wu X, et al. cisplatin antineoplastic effect Influence of berberine on in A549 cells. Chin J Lung Cancer, 2015, Aug; 18 (8): 481-486.
[30] Park S H, Sung J H, Kim E J, et al. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Brazilian J Med Biol Res, 2015, Feb; 48 (2): 111-119.
[31] GENG Dong-Sheng. Effects of Berberine on Anti-inflammation and Immune Regulation. PHARMACEUTICAL JOURNAL OF CHINESE PEOPLE'S LIBERATION ARMY. 2000, Jan; (06): 317-320.
[32] CUI Xiang, TAO Jin-hua, JIANG Shu, et al. Research on interaction between Coptidis Rhizoma extracts and intestinal bacteria. Chinese Traditional and Herbal Drugs. 2018, Aug; 49 (09): 2103-2107.
[33] SHEN Yan, WANG Zhangliu, ZHENG Huajun, et al. Protective Effects of Berberine Hydrochloride on the Intestinal Mucosal Mechanical Barrier in Mice with Ulcerative Colitis. Chin J Mod Appl Pharm, 2018 December, 35 (12): 1765-1770.
[34] Yu X T, Xu Y F, Huang Y F, et al. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice [J]. PLoS One. 2018, Mar; 13 (3): e194069.
[35] Zhu L, Zhang D, Zhu H, et al. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe (-/-) mice [J]. Atherosclerosis. 2018, Jan; 268: 117-126.
Cite This Article
  • APA Style

    Peng Hai Yan, Shen Wei Xing, Cheng Hai Bo. (2021). The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer. International Journal of Chinese Medicine, 5(4), 53-56. https://doi.org/10.11648/j.ijcm.20210504.11

    Copy | Download

    ACS Style

    Peng Hai Yan; Shen Wei Xing; Cheng Hai Bo. The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer. Int. J. Chin. Med. 2021, 5(4), 53-56. doi: 10.11648/j.ijcm.20210504.11

    Copy | Download

    AMA Style

    Peng Hai Yan, Shen Wei Xing, Cheng Hai Bo. The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer. Int J Chin Med. 2021;5(4):53-56. doi: 10.11648/j.ijcm.20210504.11

    Copy | Download

  • @article{10.11648/j.ijcm.20210504.11,
      author = {Peng Hai Yan and Shen Wei Xing and Cheng Hai Bo},
      title = {The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer},
      journal = {International Journal of Chinese Medicine},
      volume = {5},
      number = {4},
      pages = {53-56},
      doi = {10.11648/j.ijcm.20210504.11},
      url = {https://doi.org/10.11648/j.ijcm.20210504.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcm.20210504.11},
      abstract = {Background: Colorectal cancer has high incidence and mortal rate in China. Chronic inflammatory intestine diseases are ascribed to precancerous lesion of colorectal cancer because of its close relationship with each other. TCM therapy has good effect in the prevention and treatment of inflammatory bowel diseases related colorectal cancer. Objective: To explore the preventive and therapeutic effects of Coptis chinensis and traditional Chinese medicine compound containing Coptis chinensis on inflammatory bowel disease and colorectal cancer. Methods: This paper reviews the sections in classical TCM books and recent report of clinical and experimental research on the formulars composed of Coptidis Rhizoma and the single drug in treating ulcerative colitis, intestinal polyps and colorectal cancer. By analyzing the data reported in the original literature, The mostly applied herbal formulas in the clinic including Gegen Qinlian Decoction, Dark Plum Pill and Banxia Xiexin Decoction were studied in detail. Results: Coptidis Rhizoma has the function of clearing away heat and drying dampness, purging fire and detoxification, benefiting intestine and stopping diarrhea. Several formulas composed of Coptidis Rhizoma are applied to treat inflammatory bowel diseases and colorectal cancer. Conclusion: Coptidis Rhizoma and its composition has the function of inhibiting intestinal inflammation, regulating intestinal flora, protecting intestinal barrier, and etc.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Preventive and Therapeutic Effect of Coptidis Rhizoma on Inflammatory Bowel Diseases and Colorectal Cancer
    AU  - Peng Hai Yan
    AU  - Shen Wei Xing
    AU  - Cheng Hai Bo
    Y1  - 2021/12/24
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ijcm.20210504.11
    DO  - 10.11648/j.ijcm.20210504.11
    T2  - International Journal of Chinese Medicine
    JF  - International Journal of Chinese Medicine
    JO  - International Journal of Chinese Medicine
    SP  - 53
    EP  - 56
    PB  - Science Publishing Group
    SN  - 2578-9473
    UR  - https://doi.org/10.11648/j.ijcm.20210504.11
    AB  - Background: Colorectal cancer has high incidence and mortal rate in China. Chronic inflammatory intestine diseases are ascribed to precancerous lesion of colorectal cancer because of its close relationship with each other. TCM therapy has good effect in the prevention and treatment of inflammatory bowel diseases related colorectal cancer. Objective: To explore the preventive and therapeutic effects of Coptis chinensis and traditional Chinese medicine compound containing Coptis chinensis on inflammatory bowel disease and colorectal cancer. Methods: This paper reviews the sections in classical TCM books and recent report of clinical and experimental research on the formulars composed of Coptidis Rhizoma and the single drug in treating ulcerative colitis, intestinal polyps and colorectal cancer. By analyzing the data reported in the original literature, The mostly applied herbal formulas in the clinic including Gegen Qinlian Decoction, Dark Plum Pill and Banxia Xiexin Decoction were studied in detail. Results: Coptidis Rhizoma has the function of clearing away heat and drying dampness, purging fire and detoxification, benefiting intestine and stopping diarrhea. Several formulas composed of Coptidis Rhizoma are applied to treat inflammatory bowel diseases and colorectal cancer. Conclusion: Coptidis Rhizoma and its composition has the function of inhibiting intestinal inflammation, regulating intestinal flora, protecting intestinal barrier, and etc.
    VL  - 5
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

  • Sections